Biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.

Sectors
Healthcare
Life Sciences
First Invested
2015
Public/PIPES
Company Status
IPO/Public
NASDAQ: AKTX
Associated Team
Paul Walker
Website
Akari Therapeutics